GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs

    0
    15
    GILD Stock: Why Things Are Looking Up Amid Coronavirus Treatment, Cancer Drugs

    Gilead Sciences’ (GILD) coronavirus treatment, remdesivir, could bring in nearly $8 billion in new sales by 2022, an analyst said Wednesday as he upgraded GILD stock.
    XBut that’s not the only thing …
    Read More

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here